Grundinformationen
- Standard-SMILES
CC1(C)N=C(N)N=C(N)N1c1ccc(Cl)cc1- InChIKey
QMNFFXRFOJIOKZ-UHFFFAOYSA-N- Summenformel
- C11H14ClN5
- Durchschnittliche Molmasse
- 251,71 g/mol
- Monoisotopische Masse
- 251,09377313
Überblick
Cycloguanil is a triazine in which a 1,6-dihydro-1,3,5-triazine ring is substituted at N-1 by a 4-chlorophenyl group, at C-2 and -4 by amino groups and at C-6 by gem-dimethyl groups. A dihydrofolate reductase inhibitor, it is a metabolite of the antimalarial drug proguanil. It has a role as an antiinfective agent, an antiparasitic agent, an antiprotozoal drug, an antimalarial, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor and an antifolate.
Namen und Bezeichner
- Bevorzugter Name
- Cycloguanil
- IUPAC
- 1-(4-chlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine
- Englischer Name
- Cycloguanil
- Summenformel
- C11H14ClN5
- Molmasse
- 251.72
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
516-21-2- PubChem CID
- 9049
- DTXSID
DTXSID9022867- ChEMBL
CHEMBL747、CHEMBL92583- ChEBI
CHEBI:135029- UNII
- 26RM326WVN
- Nikkaji
- J6.306A
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 1
- Polarare Oberfläche (TPSA)
- 80 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 1
- Frei drehbare Bindungen
- 1
- Schwere Atome
- 17
- Formalladung
- 0
- Komplexität
- 355
Experimentelle und physikochemische Eigenschaften
Physikochemische Eigenschaften
- Schmelzpunkt
- 146 ° · 146°
- Siedepunkt
- 397.13 °C · 397.13°C (rough estimate)
- Dichte
- 1.2332 · 1.2332 (rough estimate)
- Brechungsindex
- 1.611 · 1.6110 (estimate)
- storage temp.
- -20 °C · Store at -20°C
- Löslichkeit
- Soluble in DMSO
- Aggregatzustand
- Solid
- Farbe
- White to off-white
Sicherheit und Regulatorisches
Sicherheitsdaten
- Alarmwort
- Warnung
- Gefahrenhinweise
- Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H315
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033)
Anwendungen
VerwendenAntimalarial.
Anbieter22 Anbieter
Zugehörige Reaktionen
Verknüpfte Notizen
Wird geladen…